Olivia R. Thomas

Olivia R. Thomas

Auto-generated profile, based on publicly available information

Olivia R. Thomas

Department of Neurosciences and Psychiatry, University of Toledo College of Medicine, Toledo, OH, U.S.A.

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2026 in Translation: The University of Toledo Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
OTOlivia R. Thomas
Olivia R. Thomas
MRMadhu Vishnu Sankar Reddy Rami Reddy
Madhu Vishnu Sankar Reddy Rami Reddy
JWJacob Francis Wood
Jacob Francis Wood
JTJacob J. Tan
Jacob J. Tan
THTressel Holton
Tressel Holton
Robert SmithRobert Smith
Robert Smith
Ventriculoperitoneal (VP) shunts are a common use for the treatment of hydrocephalus, which is a condition causing excessive cerebrospinal fluid (CSF) buildup in the brain. The shunt drains the CSF from the brain and into the abdomen, where it can be absorbed by the body. Although a widely used and successful procedure, it is unclear whether neurosurgical placement of this shunt may directly cause psychiatric abnormalities, especially regarding the dopaminergic system. In this paper, we first review relevant literature and discuss the dopamine circuitry in the brain. The literature suggests a shunt-associated clinical syndrome, which may include a reduction in facial and/or verbal expressivity, reduced willful movement, rigidity, and vertical gaze palsy. Typical presentation occurs within three months of a shunt revision. In patients with a VP shunt, these signs may be a strong indicator of mechanical or functional shunt malfunction. We then present two cases of hydrocephalus managed with a VP shunt, where both patients developed symptoms suggestive of psychosis and/or dopamine pathway pathology after shunt placement. We conclude that clinicians should have a suspicion for shunt-associated symptomology in patients with a history of recently treated hydrocephalus who present with psychomotor, personality, or cognitive changes.